Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc.

Key Points
SpaceX will be the largest IPO on record. The company priced its stock at $135 per share, which brings its initial market capitalization to $1.77 trillion.
SpaceX's vertical integration is unique. No other company brings together the launch, connectivity, and compute technologies needed for orbital AI data centers.
Historically, large IPO stocks have often declined during their first year on the market, and their long-term returns have frequently lagged the S&P 500.
The S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) have declined modestly this week as Wall Street prepares for the SpaceX (NASDAQ: SPCX) IPO on Friday, June 12. The event will be historic for multiple reasons: The company will raise a record $75 billion at an unprecedented valuation of $1.77 trillion, making it the largest IPO of all time.
Investment banks involved in the deal report strong demand for SpaceX stock, priced at $135 per share and trading under the ticker SPCX. In fact, the IPO is four times oversubscribed, meaning demand exceeds the number of shares available by a factor of four, according to Reuters.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Should you buy the SpaceX IPO? In the last decade, the average IPO stock gained 25% on the first trading day, but large IPOs have historically dropped sharply during the first year. Here's what you should know.
SpaceX is uniquely positioned to build and deploy orbital AI data centers
SpaceX (short for Space Exploration Technologies) breaks its business into three operating segments: space, connectivity, and artificial intelligence (AI).
1. Space
SpaceX has revolutionized space travel. In 2015, the Falcon 9 -- the world's first orbital-class rapidly reusable rocket -- successfully landed on Earth after being launched into space. No other company replicated that feat until Blue Origin in 2025. SpaceX aims to further cement its lead with the Starship system.
Starship will be the first fully and rapidly reusable spacecraft. It comprises a reusable first stage (Super Heavy booster) and second stage (the spacecraft), both engineered to return to the launch tower after flight, where they are caught in mid-air by mechanical arms. The company says Starship will reduce launch costs by 99% versus the historical average.
2. Connectivity
SpaceX could revolutionize the internet and mobile industries with Starlink, a constellation of about 10,000 broadband satellites that currently serves about 12 million subscribers. Starlink is already the largest satellite internet service, but it could eventually dominate the broader communications industry.
CEO Elon Musk says the Starlink constellation will ultimately expand tenfold to include more than 100,000 satellites. "If growth continues, Starlink will one day carry the majority of internet traffic. At that point, it is the internet and everything just connects to Starlink."
3. Artificial intelligence
SpaceX recently merged with xAI, an artificial intelligence research lab. The registration statement (Form S-1) states: "We own and operate what we believe to be the largest AI training data center clusters on Earth, including Colossus I and Colossus II." xAI also develops Grok frontier models and enterprise AI applications.
The company recently signed two big deals. It will provide compute capacity to Anthropic for $1.25 billion per month, and it will provide compute capacity to Alphabet's Google for $920 million per month. Those deals are worth $26 billion per year, which represents a material acceleration from the $3.2 billion in sales xAI reported in 2025.
Here's the big picture: SpaceX is unique in its vertical integration. No other company brings together the launch capacity, connectivity technology, and AI infrastructure needed to build and run orbital data centers. Musk believes orbital data centers (i.e., powered by the sun and cooled by space) will solve the energy constraints of terrestrial data centers.
Collectively, SpaceX estimates its total addressable market at $28.5 trillion. That figure includes $370 billion from space mission and launch services, $1.6 trillion from Starlink broadband and mobile services, and $26.5 trillion from AI infrastructure and applications.
History says SpaceX's stock will drop sharply during its first year on the public market
SpaceX will be the largest IPO on record, with an initial market capitalization of $1.77 trillion. That alone is not an issue, but it implies an absurdly expensive valuation. The company reported $19.3 billion in revenue in the past year, bringing its price-to-sales (P/S) ratio to 92.
For context, Palantir Technologies is the most expensive stock in the S&P 500 at 63 times sales. But SpaceX is going public at a valuation 46% higher, leaving plenty of downside risk, especially since large IPOs have historically declined in their first year on the market.
The chart below shows how the 10 largest U.S. IPO stocks (by market value at the IPO price) performed during their first year on the market.
10 Largest U.S. IPO Stocks
1-Year Return Post-IPO
Meta Platforms
(22%)
Uber Technologies
(25%)
Venture Global
(60%)
United Parcel Service
11%
Coupang
(45%)
Mondelez International
(8%)
Coinbase Global
(34%)
General Motors
(31%)
Visa
13%
Kenvue
(12%)
Average
(21%)
Data source: Barron's, YCharts. The chart shows how the top 10 U.S. IPO stocks performed during their first year on the public market.
As shown above, the 10 largest U.S. IPO stocks declined by an average of 21% during their first year. That may surprise readers, as IPO stocks (especially highly anticipated ones like SpaceX) frequently skyrocket on the first trading day. But they often give back those gains and then some.
More importantly, disappointing post-IPO returns are not limited to a single year for companies that go public with large market caps. The 10 largest U.S. IPO stocks (shown in the chart above) have underperformed the S&P 500 by an average of 99 percentage points since listing shares.
So, should you buy the SpaceX IPO? My answer is no. History suggests the stock could drop sharply in its first year and may underperform the S&P 500 in the long run. That doesn't mean you should forget about SpaceX. Instead, be patient and wait for more attractive buying opportunities.
Should you buy stock in Space Exploration Technologies right now?
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $439,038!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,277,804!*
Now, it’s worth noting Stock Advisor’s total average return is 942% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of June 11, 2026.
Trevor Jennewine has positions in Palantir Technologies and Visa. The Motley Fool has positions in and recommends Alphabet, Kenvue, Meta Platforms, Palantir Technologies, Uber Technologies, United Parcel Service, and Visa. The Motley Fool recommends Coinbase Global, Coupang, and General Motors. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Should You Buy the SpaceX IPO? History Says the Stock Will Make a Big Move in the First Year.

Key Points
The S&P 500 has climbed in the double digits since President Donald Trump’s inauguration.
But certain elements point toward a potential slowdown ahead.
The S&P 500 has roared higher over the past three years -- and since President Donald Trump's inauguration in January of last year, the famous benchmark has advanced more than 23%. Investors have rushed to buy high-growth players, particularly in innovative areas such as artificial intelligence (AI) and quantum computing.
And a new batch of growth companies has also rushed to take advantage of investors' appetite for high-growth stories. AI chip company Cerebras Systems recently completed the biggest initial public offering of the year, Elon Musk's SpaceX this week aims to launch what may be the largest IPO ever, and AI lab Anthropic earlier this month filed confidentially with regulators for a market debut.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
All of this is fantastic and is supportive of further stock market gains. But... my prediction is the Trump bull market may end soon. The S&P 500 Shiller CAPE ratio shows that stocks remain around their highest valuation level ever, and historically, this has led to declines. Meanwhile, inflationary pressures persist, as we can see through rising energy prices and increases in the Consumer Price Index (CPI).
But here's some good news: If the Trump bull market ends in the near future, the following two stocks, both on the rise so far this year, will keep winning anyway. Let's check them out.
1. Eli Lilly
Eli Lilly (NYSE: LLY) is a pharmaceutical giant, selling a wide variety of products that patients need regardless of the economic backdrop. That's why you can count on a certain level of revenue stability and growth even during tougher times. And today Lilly happens to be the leader in one of the highest-growth healthcare markets: obesity drugs.
Lilly is the maker of the well-known Mounjaro, commercialized for type 2 diabetes, and Zepbound, approved for weight loss. The underlying product is tirzepatide, a drug of the GLP-1 class. These drugs work by interacting with hormonal pathways involved in the digestion process.
Mounjaro and Zepbound are blockbusters, with revenue continuing to climb in the double and triple digits. On top of this, Lilly just released Foundayo, an oral weight loss drug -- Mounjaro and Zepbound are injectables. This new product should broaden the addressable market, offering Lilly a new growth driver. And the company aims to further expand this portfolio through its solid pipeline. It recently announced positive phase 3 results for GLP-1 candidate retatrutide, a potential drug that may help patients who aim for greater weight loss.
With the weight loss drug market marching toward almost $100 billion by the end of the decade, now is the perfect time to get in on this market leader.
2. Johnson & Johnson
You may know the name Johnson & Johnson (NYSE: JNJ) for consumer products such as Band-Aid brand bandages -- but the company actually spun off this consumer health business into Kenvue three years ago. The idea was to shift its focus and resources to areas that could generate the strongest growth over time, and J&J is demonstrating that this was a wise move.
Revenue in its innovative medicines and medtech businesses has been on the rise, and the recent quarter offers us a solid example of the company's direction. Innovative medicine delivered an 11% increase in sales, while medtech generated a 7.7% gain. And the company's total sales rose nearly 10% to more than $24 billion.
There's reason to be optimistic that growth will continue thanks to an enormous portfolio of powerful products: The company today has 28 products or platforms that each deliver at least $1 billion in annual sales -- and J&J aims to further grow this blockbuster portfolio.
J&J has set goals to reach $100 billion in annual revenue this year and generate double-digit growth by the end of the decade. If the company reaches these goals, and there's reason to be optimistic that it will, the stock could climb.
Any potential economic shifts shouldn't interfere with J&J's progress toward those goals -- as mentioned above, patients need their medical treatments during all market environments. So, my prediction is that even if the Trump bull market ends, this top pharma stock will keep winning.
Should you buy stock in Eli Lilly right now?
Before you buy stock in Eli Lilly, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!*
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of June 8, 2026.
Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Eli Lilly and Kenvue. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway

Key Points
SpaceX will be the largest IPO in history; the stock will have an initial market value of $1.77 trillion when it starts trading on Friday, June 12.
The 10 largest U.S. IPO stocks on record have collectively underperformed the S&P 500 by 96 percentage points since listing shares.
SpaceX's IPO price puts the valuation above 90 times sales, 48% more expensive than the most richly valued stock in the S&P 500.
SpaceX, the rocket and satellite company founded by Elon Musk, will hold its initial public offering (IPO) on Friday, June 12. The stock will be listed on the Nasdaq Exchange under the ticker symbol SPCX.
SpaceX has officially priced its IPO at $135 per share. With about 13.1 billion total shares outstanding, that gives the company an initial market capitalization of $1.77 trillion, making it the largest IPO on record.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Investment banks underwriting the IPO are reporting immense demand, but history says SpaceX is likely to underperform the S&P 500 (SNPINDEX: ^GSPC) in the long run, which means investors would be better off buying an S&P 500 index fund instead of participating in the IPO.
Here are the important details.
SpaceX stock may rocket higher initially, but history says it will underperform the S&P 500 in the long run
IPO stocks frequently jump on their first trading day. Between 2016 and 2025, over 1,100 companies listed shares on U.S. exchanges, and their stock prices increased by an average of 25% on day one, according to Jay Ritter, director of the IPO Initiative at the University of Florida.
However, the initial excitement eventually fades, and selling pressure increases as lock-up periods expire, giving insiders an exit strategy. That trend is particularly evident with larger companies. The chart below lists the 10 largest U.S. IPOs (as measured by market value at the IPO price) on record; it also shows how each stock has performed relative to the S&P 500 since going public.
IPO Stock
IPO Date
Relative Total Return Versus S&P 500
Meta Platforms
May 2012
1,123%
Uber Technologies
May 2019
(97%)
Venture Global
January 2025
(70%)
United Parcel Service
November 1999
(727%)
Coupang
March 2021
(159%)
Mondelez International
June 2001
(791%)
Coinbase Global
April 2021
(112%)
General Motors
November 2010
(685%)
Visa
March 2008
665%
Kenvue
May 2023
(107%)
Average
(96%)
Data source: Barron's, YCharts. The chart shows how the 10 largest U.S. IPO stocks (i.e., excluding foreign issuers) have performed relative to the S&P 500 since listing shares.
As shown above, the 10 largest U.S. IPO stocks have underperformed the S&P 500 by 96 percentage points since listing shares. The lesson for investors is crystal clear: Rather than participate in those IPOs, it would have been more lucrative to buy an S&P 500 index fund. And the same is probably true of the SpaceX IPO.
SpaceX will go public with a very expensive valuation of 92 times sales. For context, Palantir Technologies is currently the most richly valued stock in the S&P 500 at 62 times sales. But SpaceX stock will be 48% more expensive when it starts trading, leaving plenty of downside.
Morningstar analyst Nicolas Owens estimates SpaceX's fair value at $780 billion, implying 56% downside from its IPO valuation of $1.77 trillion. That does not mean the stock will crash immediately. CNBC's Jim Cramer thinks the company's market value could rapidly climb to $5 trillion following the IPO.
Here's the bottom line: SpaceX, with an initial valuation of $1.77 trillion, will be the largest IPO on record. The stock may initially rocket higher, but history says it will underperform the S&P 500 over the long run. That means investors would be better off buying the Vanguard S&P 500 ETF (NYSEMKT: VOO) on June 12.
The Vanguard S&P 500 ETF returned 12.3% annually over the last 15 years
The Vanguard S&P 500 ETF tracks the S&P 500, an index of 500 large U.S. companies. It includes growth and value stocks from every market sector, and covers about 80% of domestic equities and 50% of global equities by market value.
In short, the Vanguard S&P 500 ETF is a ready-made portfolio that offers exposure to many of the most influential companies in the world. The five largest positions are listed below:
Nvidia: 7.8%
Alphabet: 6.5%
Apple: 6.4%
Microsoft: 4.9%
Amazon: 4.1%
The Vanguard S&P 500 ETF has a very low expense ratio of 0.03%, meaning shareholders will pay just $3 per year on every $10,000 invested. Additionally, the index fund returned 475% (12.3% annually) over the last 15 years, compounding at a pace that would have turned $500 per month into more than $230,000.
Purchasing an S&P 500 index fund lacks the excitement of participating in the SpaceX IPO, but history says it's the more prudent investment. However, investors should still keep SpaceX on their watchlists. "We think the company has been significantly overvalued and investors will have opportunities to buy the stock at more attractive levels after the IPO," Morningstar analysts led by Nicolas Owens wrote in a recent note.
Should you buy stock in S&P 500 Index right now?
Before you buy stock in S&P 500 Index, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!*
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of June 8, 2026.
Trevor Jennewine has positions in Amazon, Nvidia, Palantir Technologies, Vanguard S&P 500 ETF, and Visa. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Kenvue, Meta Platforms, Nvidia, Palantir Technologies, Uber Technologies, United Parcel Service, Vanguard S&P 500 ETF, and Visa. The Motley Fool recommends Coinbase Global, Coupang, and General Motors. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The SpaceX IPO Is Just Days Away. History Says the Stock Will Do This When It Starts Trading.

Investors searching for reliable income in their portfolio may want to consider several consumer-focused companies that offer enticing dividend yields while also having promisng earnings outlooks and reasonable valuations.
These consumer-oriented businesses often benefit from resilient demand trends, established brands, and steady cash flows that support shareholder returns.
Furthermore, with interest rates still expected to gradually ease, consumer-centric stocks that pay dividends can provide a compelling combination of income and upside potential.
That said, here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list thanks to a favorable trend of positive EPS revisions.
Hasbro – HAS: Toy Industry Leader With Growing Profitability
Stock Price: $84
Hasbro HAS) is one of the world's largest toy and entertainment companies, owning iconic brands such as Monopoly, Nerf, Play-Doh, Magic: The Gathering, and Peppa Pig.
Hasbro has been transforming its business model by focusing on higher-margin franchises, digital gaming initiatives, and licensing opportunities. Magic: The Gathering, a popular globally traded card game (TCG), continues to be a major growth driver, helping to offset broader industry challenges and supporting stronger profitability.
Hasbro's cost-cutting efforts and portfolio optimization initiatives have improved earnings performance, while management remains focused on expanding operating margins and generating healthy free cash flow.
HAS currently offers a 3.33% annual dividend yield, making it attractive for income-oriented investors. Furthermore, improving earnings expectations and a recognized global brand portfolio make Hasbro an appealing opportunity for both yield and growth potential.
Kenvue – KVUE: Defensive Consumer Health Giant
Stock Price: $16
Kenvue KVUE is a leading consumer health company that was spun off from Johnson & Johnson JNJ) in 2023 and owns a portfolio of trusted brands including Tylenol, Neutrogena, Listerine, Band-Aid, and Aveeno.
Kenvue operates in categories that tend to remain resilient across economic cycles, providing a defensive investment profile. Demand for over-the-counter medications, personal care products, and health essentials generally remains stable regardless of broader economic conditions.
On top of that, Kenvue continues to focus on innovation, brand investment, and productivity improvements to drive earnings growth. Its strong market positions and broad global footprint provide competitive advantages that can support long-term revenue stability.
With a dividend yield at nearly 5%, Kenvue offers investors a combination of dependable income and defensive characteristics at a very affordable price tag of under $20 a share. And as a relatively new standalone company, Kenvue also has opportunities to unlock additional operational efficiencies and shareholder value.
Movado Group – MOV: High Yield Meets Strong Balance Sheet
Stock Price: $37
Movado Group MOV) designs, manufactures, and distributes watches and luxury accessories under its own brands including Movado, Concord, Ebel, Olivia Burton, and MVMT, as well as licensed brands for PVH’s PVH) Calvin Klein and Tommy Hilfiger brands, Tapestry’s TPR) Coach brand, and Hugo Boss among others.
While luxury and discretionary spending can fluctuate with economic conditions, Movado's strong balance sheet and disciplined capital allocation have helped the company navigate industry cycles effectively. To that point, Movado has historically maintained a conservative financial profile, providing flexibility during periods of softer demand.
Movado has also benefited from its diversified brand portfolio and international presence. Management has focused on inventory discipline and operational efficiency while returning capital to shareholders through its nearly 4% dividend yield.
Being one of the higher-yielding names in the consumer discretionary space, Movado’s attractive valuation, healthy balance sheet, and shareholder-friendly capital return strategy may appeal to value and income investors alike.
Bottom Line
For investors seeking income without sacrificing exposure to consumer-focused businesses, Hasbro, Kenvue, and Movado Group deserve consideration. Each stock currently offers a dividend yield above 3%, maintains recognizable consumer brands, and possesses catalysts that have supported future earnings growth.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PVH Corp. (PVH) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV

Mission Produce, Inc. AVO has completed its acquisition of Calavo Growers, Inc., marking a transformative step in its strategy to build a larger and more diversified fresh produce platform. The acquisition creates one of the most comprehensive vertically integrated fresh produce platforms in North America.
The transaction significantly strengthens the vertically integrated business model of Mission Produce, a global leader in fresh Hass avocados, by enhancing sourcing, packing, distribution and value-added food capabilities across the global produce supply chain.
The acquisition combines two of the industry's most established avocado businesses and broadens Mission Produce's portfolio beyond avocados into complementary categories, such as tomatoes, papayas and prepared foods, including guacamole. The deal also accelerates AVO’s entry into the higher-margin prepared foods segment, enhancing revenue diversification and growth opportunities.
Management expects the combination to generate operational efficiencies through improved asset utilization, expanded sourcing capabilities, enhanced supply-chain flexibility, and deeper customer relationships across retail, wholesale and foodservice channels. The enlarged platform is designed to provide greater supply reliability, scale and innovation while supporting increasing consumer demand for fresh, healthy and convenient food products.
AVO’s management described the transaction as a transformational milestone that strengthens the company's competitive position and long-term growth prospects. Calavo will continue operating as a wholly-owned subsidiary of Mission Produce, with former Calavo CEO John Lindeman remaining in a leadership role during the integration period to ensure continuity of operations and customer relationships.
As part of the transaction, Kathleen Holmgren, former chair of Calavo's board, joined Mission Produce's board of directors, bringing extensive technology and corporate leadership experience.
Under the merger terms, Calavo shareholders will receive $26.05 per share, consisting of $14.85 in cash and 0.9790 shares of Mission Produce common stock for each Calavo share. Following the transaction's completion, Calavo's shares have been suspended from trading and are expected to be delisted from Nasdaq by June 8, 2026.
What Does the Deal Mean for AVO & Investors?
Perhaps the most attractive aspect of the Calavo deal is Mission Produce's entry into the higher-margin prepared foods segment. Calavo's established guacamole and prepared-food operations offer a new growth avenue and could help diversify earnings beyond the cyclical avocado market. In addition, the combined company gains access to a broader customer base and stronger relationships with growers and distributors.
For investors, the key question is whether Mission Produce can successfully integrate Calavo and capture expected synergies. While integration risks and execution challenges remain, the transaction has the potential to boost long-term revenue growth, improve profitability and strengthen Mission's competitive position in the fresh produce industry.
The acquisition also reflects management's confidence in rising consumer demand for healthy, fresh and convenient food products. If Mission Produce delivers on its integration objectives and realizes cost and revenue synergies, the deal could serve as a meaningful catalyst for the stock in the coming years, making the Zacks Rank #3 (Hold) company worth watching in the agricultural and food distribution sector.
AVO’s Price Performance, Valuation & Estimates
Shares of Mission Produce have lost 21.1% in the past three months against the industry’s growth of 1.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, AVO trades at a forward price-to-earnings ratio of 18.06X, significantly above the industry’s average of 15.57X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AVO’s fiscal 2026 earnings suggests a year-over-year decline of 15.2%, while that for fiscal 2027 indicates growth of 6%. The company’s EPS estimates for fiscal 2026 and 2027 have remained stable in the past seven days.
Image Source: Zacks Investment Research
Picks You Can’t Miss Out On
Arko Corp. ARKO, operating a chain of convenience stores in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Arko’s 2026 earnings implies a surge of 93.3% from the year-ago reported number. ARKO has a trailing four-quarter earnings surprise of 43.2%, on average.
Kenvue Inc. KVUE operates as a consumer health company in the United States, the rest of North America, Europe, the Middle East, Africa, the Asia-Pacific and Latin America. The company currently flaunts a Zacks Rank #1.
The Zacks Consensus Estimate for Kenvue’s 2026 sales and earnings suggests growth of 3.2% and 7.4%, respectively, from the year-ago reported numbers. KVUE has a trailing four-quarter earnings surprise of 12.1%, on average.
Archer Daniels Midland Company ADM is one of the leading producers of food and beverage ingredients as well as goods made from various agricultural products. It currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Archer Daniels’ 2026 sales and earnings suggests growth of 6.5% and 32.4%, respectively, from the year-ago reported numbers. ADM has a trailing four-quarter earnings surprise of 5.4%, on average.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ARKO Corp. (ARKO) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Mission Produce Acquires Calavo Growers: What's Ahead for the Stock?

Colgate-Palmolive Company CL is striving for a balance between volume and pricing, rather than relying solely on price increases to drive revenues. In the first quarter of fiscal 2026, the company highlighted that it witnessed improved volume performance, particularly within the Asia Pacific region. Excluding the impact from the private label pet food exit, the company achieved both volume and pricing growth across all four categories and in four of its five operating divisions, reflecting broad-based business momentum.
The company stated that industry-wide category volumes remain relatively sluggish globally, making the recent acceleration in volume growth particularly encouraging. Management highlighted that volume improvement compared with the fourth quarter of fiscal 2025 was broad-based, with growth observed across nearly all divisions and categories in the first quarter of fiscal 2026. This trend was strongest in emerging markets, which the company views as a primary growth engine. Management noted that the Asia Pacific region was a significant contributor to accelerating growth trends, while Latin America continued delivering solid volume performance and market share gains.
However, pricing remains a critical lever navigating the inflationary environment and maintaining pricing power remains a key priority across the business. Management highlighted that pricing actions continue to be important for protecting margin dollars and supporting category investment. The company also emphasized that future pricing initiatives will increasingly be supported by innovation and strong value propositions across multiple price points. Management expects innovation-led pricing opportunities to continue through the remainder of the year as it focuses on balancing pricing strategy with consumer value.
Overall, Colgate appears increasingly balanced between pricing and volume growth, with emerging market momentum, innovation-led demand and pricing discipline supporting sustainable revenue growth and margin protection.
Zacks Rundown for CL
Colgate’s shares have gained 11.7% in the past six months against the industry’s decline of 4.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 23X, higher than the industry’s average of 17.68X. CL currently carries a Zacks Rank #4 (Sell).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CL’s 2026 and 2027 earnings implies year-over-year growth of 3.5% and 5.6%, respectively.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks have been discussed below:
ARKO Corp. ARKO operates a chain of convenience stores in the United States. ARKO currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ARKO's current fiscal-year sales implies a decline of 2.8%, while the same for current fiscal-year earnings implies growth of 93.3% from the year-ago reported figures. ARKO delivered a trailing four-quarter earnings surprise of 43.2%, on average.
Kenvue Inc. KVUE operates as a consumer health company in the United States, the rest of North America, Europe, the Middle East, Africa, the Asia-Pacific and Latin America. KVUE currently sports a Zacks Rank #1.
The Zacks Consensus Estimate for KVUE's current fiscal-year sales and earnings implies growth of 3.2% and 7.4%, respectively, from the year-ago actuals. KVUE delivered a trailing four-quarter negative earnings surprise of 12.1%, on average.
Krispy Kreme, Inc. DNUT produces doughnuts in the United States, the United Kingdom, Ireland, Australia, New Zealand, Mexico, Canada, Japan, and internationally. At present, DNUT Carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for DNUT’s current fiscal-year sales implies a decline of 14%, and the same for earnings implies growth of 80% from the year-ago reported figures. DNUT delivered a trailing four-quarter negative earnings surprise of 6.3%, on average.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ARKO Corp. (ARKO) : Free Stock Analysis Report
Kenvue Inc. (KVUE) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Is Colgate Too Dependent on Pricing Actions for Revenue Growth?

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Dividend ETF (Symbol: SDY) where we have detected an approximate $762.3 million dollar outflow -- that's a 3.5% decrease week over week (from 146,453,658 to 141,303,658). Among the largest underlying components of SDY, in trading today Realty Income Corp (Symbol: O) is up about 0.8%, Kenvue Inc (Symbol: KVUE) is down about 1.9%, and Kimberly-Clark Corp. (Symbol: KMB) is lower by about 2.1%. For a complete list of holdings, visit the SDY Holdings page » The chart below shows the one year price performance of SDY, versus its 200 day moving average:
Looking at the chart above, SDY's low point in its 52 week range is $131.96 per share, with $156.39 as the 52 week high point — that compares with a last trade of $148.22. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ».
Project your dividend income with confidence: Income Calendar tracks your income portfolio like a personal assistant.
Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.
Also see:
BDC Baby Bonds and Preferreds
PSB Options Chain
Technology Stocks Hedge Funds Are Selling
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

SDY, O, KVUE, KMB: Large Outflows Detected at ETF

Looking at the universe of stocks we cover at Dividend Channel, on 5/13/26, Kenvue Inc (Symbol: KVUE) will trade ex-dividend, for its quarterly dividend of $0.2075, payable on 5/27/26. As a percentage of KVUE's recent stock price of $17.33, this dividend works out to approximately 1.20%, so look for shares of Kenvue Inc to trade 1.20% lower — all else being equal — when KVUE shares open for trading on 5/13/26.
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from KVUE is likely to continue, and whether the current estimated yield of 4.79% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of KVUE shares, versus its 200 day moving average:
Looking at the chart above, KVUE's low point in its 52 week range is $14.02 per share, with $24.61 as the 52 week high point — that compares with a last trade of $17.33.
Free Report: Top 8%+ Dividends (paid monthly)
According to the ETF Finder at ETF Channel, KVUE makes up 8.76% of the Renaissance IPO ETF (Symbol: IPO) which is trading lower by about 0.5% on the day Monday. (see other ETFs holding KVUE).
In Monday trading, Kenvue Inc shares are currently off about 1.5% on the day.
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »
Also see:
Best High Yield Stocks
Top Ten Hedge Funds Holding SPSM
Floating Rate Preferreds
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

KVUE Ex-Dividend Reminder - 5/13/26

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 11:
Kenvue Inc. KVUE: This consumer health company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Kenvue Inc. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 4.7%, compared with the industry average of 0.0%.
Kenvue Inc. Dividend Yield (TTM)
BP p.l.c. BP: This company that engages in the energy business worldwide has witnessed the Zacks Consensus Estimate for its current year earnings increasing 103.5% over the last 60 days.
BP p.l.c. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 4.6%, compared with the industry average of 0.6%.
BP p.l.c. Dividend Yield (TTM)
BP p.l.c. dividend-yield-ttm | BP p.l.c. Quote
Civista Bancshares, Inc. CIVB: This financial holding company for Civista Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Civista Bancshares, Inc. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 2.9%, compared with the industry average of 2.6%.
Civista Bancshares, Inc. Dividend Yield (TTM)
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Find more top income stocks with some of our great premium screens.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Kenvue Inc. (KVUE) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Best Income Stocks to Buy for May 11th

Key Points
Realty Income rents property to many of the country's most well-known businesses.
Temporary headwinds and a rising dividend could make Clorox an eventual winner.
After the Kenvue merger, more of America's most respected brands will be under Kimberly-Clark's umbrella.
Investors have compelling anecdotal evidence that they should be cautious about the market. The Shiller P/E ratio, an indicator of the market's long-term valuation, is at 41, its highest level since the dot-com bubble.
Moreover, Warren Buffett's former company, Berkshire Hathaway, holds almost $397 billion in liquidity, a record level, and more than the nearly $330 billion value of its stock portfolio. That could indicate it is accumulating cash in anticipation of a discounted market.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
However, investors should note that Berkshire remains heavily invested in stocks, and certainly, some stocks can offer value in the current market, particularly among dividend payers. Knowing that, these three consumer names are probably a good place to invest cash while earning generous dividend payments.
1. Realty Income
Realty Income (NYSE: O) leases single-tenant properties to many of the world's best-known corporations. Companies ranging from Walmart to FedEx to Wynn Resorts operate businesses in properties owned by this real estate investment trust (REIT).
That client base delivers steady revenue and a 99% occupancy rate. With that, the company continues to develop and acquire additional properties.
That base also helps Realty Income maintain its reputation as the "monthly dividend company." True to that name, it has made a payout every month since 1994, increasing the amount at least once per year. At $3.25 per year, its dividend yield is 5.1%, far above the 1.1% average for the S&P 500 (SNPINDEX: ^GSPC).
Fortunately, it earned $4.25 per share in funds from operations (FFO) income, a measure of a REIT's free cash flow. That likely means it can continue to support its dividend and fund payout hikes.
Moreover, while investors may focus on its 55 P/E ratio, it sells at a price-to-FFO ratio of around 15, indicating the stock is much cheaper than it might appear. That increases the likelihood the stock will move higher over the long term, and its dividend should pay shareholders generously in the meantime.
2. Clorox
Clorox (NYSE: CLX) is a consumer staples stock that has struggled to gain respect in recent years. In addition to its flagship bleach brand, the company owns Kingsford charcoal, Hidden Valley salad dressing, and Burt's Bees personal care products.
Clorox stock surged during the pandemic amid temporarily high demand for cleaning supplies, but unfortunately, a 2023 cyberattack and implementation of a new CRM system led to stock selling. More recently, rising input costs squeezed margins, forcing a downward revision in sales and earnings forecasts.
However, Clorox has a streak of annual dividend increases spanning decades. Consequently, its $4.96-per-share yearly dividend yields about 5.6%.
Admittedly, its $380 million in free cash flow over the trailing 12 months was well short of the $602 million in dividend costs for the period. Still, a $476 million venture termination payment, a one-time charge, caused that shortfall. Furthermore, since abandoning the streak of payout hikes would hurt the stock's reputation, the company will likely maintain the streak despite its struggles.
Furthermore, Clorox's stock is also cheap. Amid its troubles, its P/E ratio has fallen to 14, well below the S&P 500 average of 31. Assuming investors capitalize on that discounted price, the strength of Clorox's brands should bring stability, and the dividend will likely deliver increasing returns as investors wait for improvement.
3. Kimberly-Clark
Kimberly-Clark (NASDAQ: KMB) has long maintained its stability with brands like Kleenex, Huggies, and Cottonelle. Moreover, it is about to expand its reach with the upcoming merger with Kenvue, formerly a Johnson & Johnson division. This buyout brings famous brands such as Tylenol, Listerine, Neutrogena under its umbrella.
The Kenvue merger may make some investors nervous. Kimberly-Clark's $32 billion market cap is well below the $48.7 billion cost of the deal, meaning the company will almost certainly have to issue shares to close the deal.
Concerns about the deal's cost have likely contributed to a significant decline in Kimberly-Clark stock. However, the lower stock price may indicate investors have priced in much of the upcoming stock dilution. In addition, many investors believe synergies, the disposition of lower-margin businesses, and the company's financial strength will make the deal work.
Fortunately, its $5.12-per-share dividend has increased for 54 straight years, making it a Dividend King, or a company that has raised its annual dividend for at least 50 consecutive years. The company yields 5.2%. Also, its $1.8 billion in free cash flow over the trailing 12 months was just above the $1.7 billion dividend cost, indicating it can still afford its payout.
Additionally, the pullback in the stock price has taken its P/E ratio to just 15. That low valuation buys investors a stock that owns many of America's most respected consumer brands. With more brands coming under its control following the merger, Kimberly-Clark will likely protect investor wealth while continuing to raise its dividend.
Should you buy stock in Realty Income right now?
Before you buy stock in Realty Income, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Realty Income wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $475,926!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,296,608!*
Now, it’s worth noting Stock Advisor’s total average return is 981% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of May 9, 2026.
Will Healy has positions in Berkshire Hathaway, Clorox, and Realty Income. The Motley Fool has positions in and recommends Berkshire Hathaway, Kenvue, Realty Income, and Walmart. The Motley Fool recommends FedEx and Johnson & Johnson. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	43.05 21.50
Price/Sales	2.83 0.83
P/B	4.32 1.91
P/FCF	24.27 20.34

Indicator	TTM Median
ROE	13.30 14.61
ROA	3.92 6.60
Net Worth	45.56 1.43
Quick Ratio	0.69 0.79
Current Ratio	0.99 1.34

Indicator	TTM Median
Net Profit Margin	6.88 6.57
Operating Margin	11.76 8.82
Gross Margin	57.78 33.57
Return on tangible equity	-13.92 26.52

Indicator	TTM Median
EPS	0.28 0.57
EPS Forecast	0.27 0.44
Revenue	3.90B 141.50M
Gross Profit	2.28B —
EBITDA	836.00M —

Kenvue Inc.

Recent quarterly and TTM performance

Valuation

Debts

Efficiency

Other ratios

Revenue